News

  • Sleep Cycle and Carnegie Mellon to explore sleep data to detect outbreaks

    AI sleep technology company Sleep Cycle has announced the kickoff of a five-year research collaboration with The Delphi Group at Carnegie Mellon University (CMU). This collaboration focuses on understanding how privacy-preserved data and sleep-based signals, such as nighttime cough patterns, may complement and enhance traditional respiratory disease surveillance systems and early detection of both seasonal [...]

  • nyra health receives €20 million to expand AI neuropathy platform

    AI neuro platform nyra health has raised €20m in a Series A round to expand its AI-based neurological therapy services in Europe and the US. The Vienna-based company said the funding will be used to expand its technology platform in the DACH region, accelerate growth in the US and pursue its aim of setting a [...]

  • GSK to acquire 35Pharma in US$950m deal

    GSK has agreed to acquire Canadian drugmaker 35Pharma for up to US$950m, gaining an experimental treatment for pulmonary arterial hypertension. The drug, HS235, has completed Phase 1 testing in healthy volunteers. GSK said it plans to move the treatment into studies targeting pulmonary arterial hypertension or another form of pulmonary hypertension linked to heart failure. [...]

  • X-on Health launches Omni Consult to transform Primary Care triage and patient access

    X-on Health has announced the official launch of Omni Consult, a major upgrade to its Surgery Connect platform that fundamentally reshapes how patients submit medical requests and how GP practices manage triage workflows. The new functionality unifies patient submissions across channels into a single, structured stream, helping GP practices accelerate clinical response times while reducing [...]

  • mRNA nanobodies show promise in colorectal cancer

    mRNA nanobodies have shown promise in colorectal cancer, with a preclinical study reporting tumour suppression using lipid nanoparticle-delivered anti-PD-L1 therapy. An original study published in eGastroenterology describes how lipid nanoparticles carrying nucleoside-modified mRNA encoding anti-PD-L1 nanobodies suppressed tumour growth in both sporadic and colitis-associated colorectal cancer models. Colorectal cancer is the third most common cancer [...]

  • €1m digital mental health strategy for Ireland

    Ireland has published a €1m digital mental health strategy outlining national plans for digital tools, shared records and technology to improve mental health services. The strategy focuses on access, communications, digital tools, co-production, research, innovation and technology. Key initiatives include the HSE Health App, national shared care record, community care record and electronic health records. [...]

  • Building trust for transformation: Rethinking innovation in digital health

    By David Montano, EMEA Portfolio Manager - Clinician Productivity Solutions, Solventum Innovation in healthcare advances deliberately, and for good reason. Established clinical practices earn the trust of healthcare professionals by ensuring patient safety, and any change must be rigorously evaluated. Transformation of existing workflows, however flawed they may be, rarely succeeds through top-down disruption. Instead, [...]

  • US$80m grant supports exceptional longevity research

    A US$80m grant will support exceptional longevity research into families whose members live far longer than average, as scientists look for genetic clues to healthy ageing. The funding renews support for the Long Life Family Study, a long-running international project examining multiple generations of families with unusually high numbers of people living to 100 and [...]

  • Hims & Hers beats Q4 earnings forecasts

    Hims & Hers Health beat Q4 earnings forecasts, though shares fell 2 per cent in aftermarket trading after the telehealth firm issued full-year guidance largely in line and a softer first quarter. The company reported Q4 earnings per share of US$0.08, ahead of analyst expectations of $0.05. Revenue rose to US$617.8m, compared with consensus forecasts [...]

  • LTIMindtree wins US$100m medtech deal

    LTIMindtree has secured a seven-year US$100m medtech deal to develop and support hearing aids and related digital tools for a European medical technology company. The Indian IT services company said the Europe-based client, which provides hearing solutions, has not been named. Under the agreement, LTIMindtree will develop and support the client’s main hearing [...]